Mounting researches have highlighted that tumor burden mutation (TMB) was associated with upregulation of CD8 + T cell infiltration, which could identify cancer cells and then execute antitumor response (Rizvi et al., 2015; McGranahan et al., 2016; Chan et al., 2019). The gene discussed is CD8A; the disease is neoplasm.